IGF-1 LR3 Peptide Overview
IGF-1 LR3 w BAC WATER is a modified insulin-like growth factor-1 peptide engineered with an extended amino acid sequence and amino acid substitutions that significantly extend its biological half-life compared to native IGF-1. This research-grade peptide from Driada Medical represents a sophisticated tool for investigating growth factor signalling pathways, cellular proliferation mechanisms, and tissue development processes in controlled laboratory environments. The Long R3 variant demonstrates enhanced stability and prolonged activity in cell culture systems, making it particularly valuable for extended research protocols examining growth factor biology.
Laboratory Research Applications
Research scientists studying growth factor biology frequently examine IGF-1 LR3 in various experimental contexts, including cellular proliferation studies, tissue engineering research, and metabolic pathway investigations. The peptide’s extended half-life allows researchers to analyse sustained growth factor signalling effects over longer experimental timeframes compared to native IGF-1. Cell culture studies often investigate IGF-1 LR3’s interaction with IGF-1 receptors and insulin receptors, examining downstream signalling cascades including the PI3K/Akt pathway. Metabolic researchers evaluate the compound’s effects on glucose uptake, protein synthesis, and cellular energy metabolism. The included bacteriostatic water ensures proper reconstitution and maintains peptide stability throughout research protocols. Research teams at Stroid UK Shop increasingly utilise IGF-1 LR3 in studies examining growth factor resistance mechanisms and cellular senescence pathways. Scientists working with IGF-1 peptide compounds often compare LR3 variants against native sequences to understand structure-activity relationships. Research applications extend to tissue regeneration studies, where investigators examine the peptide’s effects on cellular repair mechanisms. Some research teams combine IGF-1 LR3 studies with selective androgen receptor modulators to investigate potential synergistic effects on cellular growth pathways. Advanced research protocols may incorporate IGF-1 LR3 alongside other research peptides to examine complex growth factor interactions in multi-factorial experimental designs.
Technical Specifications
| Parameter | Specification |
|---|---|
| Molecular Weight | Verify with supplier |
| CAS Number | Verify with supplier |
| Sequence Length | 83 amino acids |
| Manufacturer | Driada Medical |
| Form | Lyophilised powder with BAC water |
| Storage | -20°C lyophilised, 2-8°C reconstituted |
| Solubility | Water soluble |
Research Compliance Statement
This IGF-1 LR3 w BAC WATER product is manufactured by Driada Medical exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or any form of in-vivo administration. Research institutions and qualified scientists should handle this material according to standard laboratory safety protocols and applicable regulations governing peptide research compounds.
